Yu-Ting Gan,Xing-Ying Liu,Hua Liu et al.
Yu-Ting Gan et al.
Role of Pre-Endoscopic Metoclopramide in Patients With Acute Upper Gastrointestinal Bleeding: Meta-Analysis of Randomized Controlled Trials [0.03%]
急性上消化道出血患者内镜前促胃肠动力药物使用效果的系统评价和 meta 分析
Aamir Saeed,Marc Hersh,Katherine Duffey et al.
Aamir Saeed et al.
Safa Souissi,Ons Charfi,Israa Dahmani et al.
Safa Souissi et al.
Psychedelic Therapy: A Primer for Primary Care Clinicians-5-Methoxy-N,N-Dimethyltryptamine [0.03%]
幻觉疗法：初级保健临床医生的指南-5-甲氧基-N，N-二甲基色胺
Burton J Tabaac,Kenneth Shinozuka,Anne Weisman et al.
Burton J Tabaac et al.
Background: 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT), also officially known as mebufotenin, is a naturally occurring serotonergic psychedelic alkaloid found in the venom of the Sonoran Desert toad (Incilius alvarius) ...
Drug Interactions Between Direct Oral Anticoagulants and Nonsteroidal Anti-inflammatory Drugs: A Clinical Risk-Benefit Analysis With Focus on Special Populations [0.03%]
直接口服抗凝药物与非甾体类抗炎药相互作用的临床风险效益分析及特殊人群用药探讨
Antonella Mameli,Francesco Marongiu,Doris Barcellona
Antonella Mameli
Background: Direct oral anticoagulants (DOACs) are widely used in patients with atrial fibrillation and venous thromboembolism. Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently coprescribed in this population ...
Ikram Fazaa,Fatma Zgolli,Rihab Ouerghi et al.
Ikram Fazaa et al.
Dapagliflozin Effects in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The DAPA-STEMI Randomized Clinical Trial [0.03%]
达格列净在行直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者中的疗效：DAPA-STEMI随机临床试验
Hoda Afsharirad,Samad Ghaffari,Elnaz Javanshir et al.
Hoda Afsharirad et al.
Background: Acute myocardial infarction (MI) is associated with a high incidence of morbidity and mortality. Sodium-glucose cotransporter 2 (SGLT2) inhibitors are antidiabetic medications known for their favorable effects...
Can High-Dose Valacyclovir Alter the Course of Maternal and Fetal Cytomegalovirus Infection in the Second and Third Trimesters? A Case Report and Review of Literature [0.03%]
高剂量伐昔洛韦治疗二期和三期宫内CMV感染可行性分析：个例报告及文献回顾
Mohammadreza Salehi,Zahra Panahi,Hossein Khalili et al.
Mohammadreza Salehi et al.
Yu-Ting Gan,Jia-Luo Cai
Yu-Ting Gan
Safety and Tolerability of Multimodal Therapy (Ivermectin, Doxycycline, Vitamin C, Vitamin D, and Zinc) With or Without Famotidine in Australian Patients With COVID-19 Infection: A Pilot Cohort Trial [0.03%]
ivermectin、多西环素、维生素C、维生素D和锌，加或不加法莫替丁治疗COVID-19感染的澳大利亚患者的疗效和耐受性：一项队列试验
Lucas A McLindon,Karin Ried,Bruce Wauchope et al.
Lucas A McLindon et al.
Background: In 2020, COVID-19 caused by the SARS-CoV-2 emerged as a global pandemic. Combination therapies for viral illnesses may be more effective than single-agent therapies in reducing symptoms and preventing disease ...